Skip to main content
logo
Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland flag Poland · Delayed Price · Currency is PLN
70.70
-2.10 (-2.88%)
Aug 5, 2026, 5:00 PM CET

WSE:CTX Financials Overview

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.384.6615.8313.29.163.99
Revenue Growth
-82.89%-70.55%19.88%44.15%129.75%-
Gross Profit
1.813.2210.66.97.073.25
Operating Income
-33.82-43.56-38.97-73.02-38.36-31.71
Net Income
-42.65-42-38.43-70.58-35.89-32.57
Earnings Per Share
-7.76-7.61-8.25-15.19-8.58-7.93
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
17.8932.1139.2675.790.97117.94
Total Debt
3.193.585.643.784.628.18
Net Cash (Debt)
14.6928.5333.6271.9386.34109.76
Net Cash Growth
-74.10%-15.13%-53.26%-16.70%-21.34%-
Net Cash Per Share
2.665.177.2215.0819.8225.19

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-72.98-37.32-31.88-52.2-22.95-28.47
Capital Expenditures
-0.19-0.21-0.42-3.01-0.89-5.11
Free Cash Flow
-73.17-37.53-32.3-55.21-23.84-33.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
75.99%68.99%66.95%52.28%77.21%81.41%
Operating Margin
-1419.82%-934.78%-246.24%-553.11%-418.91%-795.51%
Pretax Margin
-476.41%-901.22%-242.82%-534.25%-391.94%-817.16%
Profit Margin
-2272.46%-901.22%-242.82%-534.69%-391.94%-817.16%
FCF Margin
-3071.66%-805.36%-204.12%-418.22%-260.32%-842.60%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-166.476.856.85--
PS Ratio
188.5785.1114.6934.8472.82186.20